Clinical Profile and Treatment Outcome of Patients with Trigeminal Neuralgia: A Retrospective study in a Tertiary Hospital of Eastern Nepal


Trigeminal neuralgia


Introduction: Neuropathic orofacial pain is common non-dontogenic pain. Diagnosis relies primarily on history taking with less of pathologic change visible. Trigeminal neuralgia (TGN) is a common neuropathic pain affecting the maxillofacial region of fifth cranial nerve (V).

Objective: To assess clinical characteristics, effective therapeutic regimen, side effect, radiographic and laboratory investigation in Trigeminal neuralgia patients.

Methods: Retrospective study included all patients visiting the department with records from 2014 to 2021. After ethical approval for study, eighty patients were diagnosed based on ICHD3 criteria. Patient with atypical feature with sensory deficit underwent CT OR MRI to rule of mass or lesion along the cerebello-pontine angle recess and other organic cause. The data were analysed using SPSS version 11.5 and Microsoft Excel 2017.

Results: A total of 80 patients were retrieved. The common side affected were right 46 (57.5%) followed by left 28 (35%), bilateral four (5%) and anterior region two (2.5%). The most common branch involved was mandibular followed by maxillary branch and combination. Management was primarily done by carbamazepine (CBZ) or in combination. Common side effects were drowsiness, dizziness, nausea and diplopia. CT scan and MRI showed space occupying lesion in three cases. Refractory cases underwent neurolysis and symptomatic and few classical TGN cases were sent for surgical management.

Conclusions: Diagnosis of Trigeminal neuralgia is primarily based on clinical characteristic due to high cost and unavailability of imaging and nerve testing. Treatment is by single or multiple drugs with adjunct therapy.



Bagheri SC, Farhidvash F, Perciaccante VJ. Diagnosis and treatment of patients with trigeminal neuralgia. J Am Dent Assoc. 2004;135(12):1713-7.

Okeson JP. Bell's orofacial pains: the clinical management of orofacial pain. Sixth edition, Quintessence Publishing Co, Inc.

De Toledo IP, Conti Réus J, Fernandes M, Luís Porporatti A, Peres MA, Takaschima A, et al. Prevalence of trigeminal neuralgia A systematic review. J Am Dent Assoc. 2016;147(7):570-6.

Headache classification committee of the international headache society (ihs). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.

Merskey H, Bogduk N. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms, 2nd ed, IASP Press, Seattle 1994, 59-71.

Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence, Eur J Pain. 2002;6:61-8.

Love S, Coakham HB. Trigeminal neuralgia: Pathology and pathogenesis. Brain, 2001;124:2347-60.

Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, rochester, minnesota, 1945-1984. Ann Neurol 1990;27:89-95.

Sharma GR, Jha RK, Poudel P, Adhikari DR, Bista P. Microvascular decompression for trigeminal neuralgia: Our experiences at bir hospital. Nep J Neurosci 2017;14(2):3-7.

Loh HS, Ling SY, Shanmuhasuntharam P, Zain R, Yeo JF, Khoo SP. Trigeminal neuralgia. A retrospective survey of a sample of patients in singapore and malaysia. Aust Dent J 1998;43:188-91.

Loeser JD. Tic douloureux. Pain Res Manag. 2001;6:156-65.

Darlow LA, Brooks ML, Quinn PD. Magnetic resonance imaging in the diagnosis of trigeminal neuralgia. J Oral Maxillofac Surg. 1992;50:621-26.

Bowsher D. Trigeminal neuralgia: a symptomatic study of 126 successive patients with and without previous interventions. The Pain Clinic. 2000;12:93-101.

Di Stefano G, La Cesa S, Truini A, Cruccu G. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 2014;9:15-34.

BendtsenaL, Zakrzewska JM, Abbott J, Braschinskye M , Stefano GD, Donnet A, et al. European academy of neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26:831-49.

Sarideechaigul W, Kithuandee A, Siritapetawee M, Butda P, Jorns TP. Profiling of patients presenting with trigeminal neuralgia and outcome of medical management in tertiary care centre. J Med Assoc Thai. 2019;102:57-62.

Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, rochester, minnesota, 1945-1984. Ann Neurol. 1990;27(1):89-95.

Jainkittivong A, Aneksuk V, Langlais RP .Trigeminal neuralgia: A retrospective study of 188 Thai cases. Gerodontology. 2012;29(2):611-7.

Ayele BA, Mengesha AT and Zewde YZ. Clinical characteristics and associated factors of trigeminal neuralgia: Experience from addis ababa, ethiopia. BMC Oral Health. 2020;20:244-51.

Priyanka Debta P, Sarode G, Sarode S, Sahu MP. Natural history of trigeminal neuralgia - A hospital-based retrospective study. Oral Dis. 2020;26(3):647-55.

Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg 2007;21:253-61.

Gomez-Arguelles JM, Dorado R, Sepulveda JM et al. Oxcarbazepine monotherapy in carbamazepine unresponsive trigeminal neuralgia. J Clin Neuro Sci 2008; 15:516-9.

Zakrewska JM, Patsalos PN. Oxcarbazepine: A new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry.1989;52:472-6.

Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the quality standards subcommittee of the american academy of neurology and the european federation of neurological societies. Neurology 2008;71:1183-90.

Harris W. An analysis of 1,433 cases of paroxysmal trigeminal neuralgia (trigeminal tic) and the end-results of gasserian alcohol injection. Brain.1940;63:209-24.